PEGylated Factor VIII fusion protein (Furen Pharmaceutical Group)

N/A

Report date: 2025/03/20 15:27:25

Base Information

Drug NamePEGylated Factor VIII fusion protein (Furen Pharmaceutical Group)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFuren Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFuren Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A